China Drug Makers Increasingly See Innovation As Way To Expand
This article was originally published in PharmAsia News
Executive Summary
Hutchison China MediTech's recent announcement of the start of clinical trials for its HMPL-013 (fruquintinib) colorectal cancer drug was an indicator of China's move toward innovative medicines.